Hospital-Acquired Infection Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Hospital-Acquired Infection Diagnostics Market to 2027 - Global Analysis and Forecasts By Product (Instruments and Reagents, Consumables); Test Type (Molecular Diagnostics, Urinalysis and Immunoassay); Application (Disease Testing and Drug-Resistance Testing); Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site infections, Gastrointestinal Infections, Urinary Tract Infections and Others.)

Report Code: TIPRE00004163 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Hospital-Acquired Infection are acquired during hospitalization, or when admitted into a nursing home, rehabilitation facility, outpatient clinic or other clinical setting. These can be acquired from an infected patient, outside environment, or from a staff of that facility.

MARKET DYNAMICS
The Hospital-Acquired Infection Diagnostics market is anticipated to grow in the forecast, owing to the factors such as rise in geriatric population, demand for hospital-acquired infection diagnostics from middle and low-income economies and development of technologically advanced diagnostic products. Nevertheless, decreasing prevalence of nosocomial infections in the developed countries and lack of awareness regarding HAI.

MARKET SCOPE
The "Global Hospital-Acquired Infection Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hospital-Acquired Infection Diagnostics market with detailed market segmentation by Product, Test Type, Application, Infection Type and geography. The global Hospital-Acquired Infection Diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Hospital-Acquired Infection Diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Hospital-Acquired Infection Diagnostics market is segmented on the basis of Product, Test Type, Application and Infection Type. Based on Product the market is segmented into Instruments & Reagents and Consumables. Based on Test Type the market is segmented into Molecular Diagnostics, Urinalysis and Immunoassay. Based on Application the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Infection Type the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site infections, Gastrointestinal Infections, Urinary Tract Infections and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Hospital-Acquired Infection Diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital-Acquired Infection Diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Hospital-Acquired Infection Diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital-Acquired Infection Diagnostics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Hospital-Acquired Infection Diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hospital-Acquired Infection Diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for Hospital-Acquired Infection Diagnostics market in the global market. Below mentioned is the list of few companies engaged in the Hospital-Acquired Infection Diagnostics market.

The report also includes the profiles of Hospital-Acquired Infection Diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • BioMerieux
  • Abbott Laboratories
  • Alere, Inc.
  • Roche AG
  • Siemens Healthcare
  • Becton Dickenson
  • Cepheid Inc.
  • Thermo Fisher Scientific
  • Seegene, Inc.
  • Qiagen
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hospital-Acquired Infection Diagnostics Market - By Product
1.3.2 Hospital-Acquired Infection Diagnostics Market - By Test Type
1.3.3 Hospital-Acquired Infection Diagnostics Market - By Application
1.3.4 Hospital-Acquired Infection Diagnostics Market - By Infection Type
1.3.5 Hospital-Acquired Infection Diagnostics Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS AND REAGENTS
7.3.1. Overview
7.3.2. Instruments and Reagents Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
8. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. MOLECULAR DIAGNOSTICS
8.3.1. Overview
8.3.2. Molecular Diagnostics Market Forecast and Analysis
8.4. URINALYSIS AND IMMUNOASSAY
8.4.1. Overview
8.4.2. Urinalysis and Immunoassay Market Forecast and Analysis
9. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DISEASE TESTING AND DRUG-RESISTANCE TESTING
9.3.1. Overview
9.3.2. Disease Testing and Drug-Resistance Testing Market Forecast and Analysis
10. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - INFECTION TYPE
10.1. OVERVIEW
10.2. INFECTION TYPE MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL ACQUIRED PNEUMONIA
10.3.1. Overview
10.3.2. Hospital Acquired Pneumonia Market Forecast and Analysis
10.4. BLOODSTREAM INFECTIONS
10.4.1. Overview
10.4.2. Bloodstream Infections Market Forecast and Analysis
10.5. SURGICAL SITE INFECTIONS
10.5.1. Overview
10.5.2. Surgical Site infections Market Forecast and Analysis
10.6. GASTROINTESTINAL INFECTIONS
10.6.1. Overview
10.6.2. Gastrointestinal Infections Market Forecast and Analysis
10.7. URINARY TRACT INFECTIONS AND OTHERS.
10.7.1. Overview
10.7.2. Urinary Tract Infections and Others. Market Forecast and Analysis
11. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Hospital-Acquired Infection Diagnostics Market Overview
11.1.2 North America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis
11.1.3 North America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Product
11.1.4 North America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Test Type
11.1.5 North America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Application
11.1.6 North America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Infection Type
11.1.7 North America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Hospital-Acquired Infection Diagnostics Market
11.1.7.1.1 United States Hospital-Acquired Infection Diagnostics Market by Product
11.1.7.1.2 United States Hospital-Acquired Infection Diagnostics Market by Test Type
11.1.7.1.3 United States Hospital-Acquired Infection Diagnostics Market by Application
11.1.7.1.4 United States Hospital-Acquired Infection Diagnostics Market by Infection Type
11.1.7.2 Canada Hospital-Acquired Infection Diagnostics Market
11.1.7.2.1 Canada Hospital-Acquired Infection Diagnostics Market by Product
11.1.7.2.2 Canada Hospital-Acquired Infection Diagnostics Market by Test Type
11.1.7.2.3 Canada Hospital-Acquired Infection Diagnostics Market by Application
11.1.7.2.4 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type
11.1.7.3 Mexico Hospital-Acquired Infection Diagnostics Market
11.1.7.3.1 Mexico Hospital-Acquired Infection Diagnostics Market by Product
11.1.7.3.2 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type
11.1.7.3.3 Mexico Hospital-Acquired Infection Diagnostics Market by Application
11.1.7.3.4 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type
11.1.7.4 US Hospital-Acquired Infection Diagnostics Market
11.1.7.4.1 US Hospital-Acquired Infection Diagnostics Market by Product
11.1.7.4.2 US Hospital-Acquired Infection Diagnostics Market by Test Type
11.1.7.4.3 US Hospital-Acquired Infection Diagnostics Market by Application
11.1.7.4.4 US Hospital-Acquired Infection Diagnostics Market by Infection Type
11.2. EUROPE
11.2.1 Europe Hospital-Acquired Infection Diagnostics Market Overview
11.2.2 Europe Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis
11.2.3 Europe Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Product
11.2.4 Europe Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Test Type
11.2.5 Europe Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Application
11.2.6 Europe Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Infection Type
11.2.7 Europe Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Hospital-Acquired Infection Diagnostics Market
11.2.7.1.1 Germany Hospital-Acquired Infection Diagnostics Market by Product
11.2.7.1.2 Germany Hospital-Acquired Infection Diagnostics Market by Test Type
11.2.7.1.3 Germany Hospital-Acquired Infection Diagnostics Market by Application
11.2.7.1.4 Germany Hospital-Acquired Infection Diagnostics Market by Infection Type
11.2.7.2 France Hospital-Acquired Infection Diagnostics Market
11.2.7.2.1 France Hospital-Acquired Infection Diagnostics Market by Product
11.2.7.2.2 France Hospital-Acquired Infection Diagnostics Market by Test Type
11.2.7.2.3 France Hospital-Acquired Infection Diagnostics Market by Application
11.2.7.2.4 France Hospital-Acquired Infection Diagnostics Market by Infection Type
11.2.7.3 Italy Hospital-Acquired Infection Diagnostics Market
11.2.7.3.1 Italy Hospital-Acquired Infection Diagnostics Market by Product
11.2.7.3.2 Italy Hospital-Acquired Infection Diagnostics Market by Test Type
11.2.7.3.3 Italy Hospital-Acquired Infection Diagnostics Market by Application
11.2.7.3.4 Italy Hospital-Acquired Infection Diagnostics Market by Infection Type
11.2.7.4 Spain Hospital-Acquired Infection Diagnostics Market
11.2.7.4.1 Spain Hospital-Acquired Infection Diagnostics Market by Product
11.2.7.4.2 Spain Hospital-Acquired Infection Diagnostics Market by Test Type
11.2.7.4.3 Spain Hospital-Acquired Infection Diagnostics Market by Application
11.2.7.4.4 Spain Hospital-Acquired Infection Diagnostics Market by Infection Type
11.2.7.5 United Kingdom Hospital-Acquired Infection Diagnostics Market
11.2.7.5.1 United Kingdom Hospital-Acquired Infection Diagnostics Market by Product
11.2.7.5.2 United Kingdom Hospital-Acquired Infection Diagnostics Market by Test Type
11.2.7.5.3 United Kingdom Hospital-Acquired Infection Diagnostics Market by Application
11.2.7.5.4 United Kingdom Hospital-Acquired Infection Diagnostics Market by Infection Type
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Hospital-Acquired Infection Diagnostics Market Overview
11.3.2 Asia-Pacific Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis
11.3.3 Asia-Pacific Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Test Type
11.3.5 Asia-Pacific Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Infection Type
11.3.7 Asia-Pacific Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Hospital-Acquired Infection Diagnostics Market
11.3.7.1.1 Australia Hospital-Acquired Infection Diagnostics Market by Product
11.3.7.1.2 Australia Hospital-Acquired Infection Diagnostics Market by Test Type
11.3.7.1.3 Australia Hospital-Acquired Infection Diagnostics Market by Application
11.3.7.1.4 Australia Hospital-Acquired Infection Diagnostics Market by Infection Type
11.3.7.2 China Hospital-Acquired Infection Diagnostics Market
11.3.7.2.1 China Hospital-Acquired Infection Diagnostics Market by Product
11.3.7.2.2 China Hospital-Acquired Infection Diagnostics Market by Test Type
11.3.7.2.3 China Hospital-Acquired Infection Diagnostics Market by Application
11.3.7.2.4 China Hospital-Acquired Infection Diagnostics Market by Infection Type
11.3.7.3 India Hospital-Acquired Infection Diagnostics Market
11.3.7.3.1 India Hospital-Acquired Infection Diagnostics Market by Product
11.3.7.3.2 India Hospital-Acquired Infection Diagnostics Market by Test Type
11.3.7.3.3 India Hospital-Acquired Infection Diagnostics Market by Application
11.3.7.3.4 India Hospital-Acquired Infection Diagnostics Market by Infection Type
11.3.7.4 Japan Hospital-Acquired Infection Diagnostics Market
11.3.7.4.1 Japan Hospital-Acquired Infection Diagnostics Market by Product
11.3.7.4.2 Japan Hospital-Acquired Infection Diagnostics Market by Test Type
11.3.7.4.3 Japan Hospital-Acquired Infection Diagnostics Market by Application
11.3.7.4.4 Japan Hospital-Acquired Infection Diagnostics Market by Infection Type
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Hospital-Acquired Infection Diagnostics Market Overview
11.4.2 Middle East and Africa Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis
11.4.3 Middle East and Africa Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Test Type
11.4.5 Middle East and Africa Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Infection Type
11.4.7 Middle East and Africa Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Hospital-Acquired Infection Diagnostics Market
11.4.7.1.1 South Africa Hospital-Acquired Infection Diagnostics Market by Product
11.4.7.1.2 South Africa Hospital-Acquired Infection Diagnostics Market by Test Type
11.4.7.1.3 South Africa Hospital-Acquired Infection Diagnostics Market by Application
11.4.7.1.4 South Africa Hospital-Acquired Infection Diagnostics Market by Infection Type
11.4.7.2 Saudi Arabia Hospital-Acquired Infection Diagnostics Market
11.4.7.2.1 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Product
11.4.7.2.2 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Test Type
11.4.7.2.3 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Application
11.4.7.2.4 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Infection Type
11.4.7.3 U.A.E Hospital-Acquired Infection Diagnostics Market
11.4.7.3.1 U.A.E Hospital-Acquired Infection Diagnostics Market by Product
11.4.7.3.2 U.A.E Hospital-Acquired Infection Diagnostics Market by Test Type
11.4.7.3.3 U.A.E Hospital-Acquired Infection Diagnostics Market by Application
11.4.7.3.4 U.A.E Hospital-Acquired Infection Diagnostics Market by Infection Type
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Hospital-Acquired Infection Diagnostics Market Overview
11.5.2 South and Central America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis
11.5.3 South and Central America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Product
11.5.4 South and Central America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Test Type
11.5.5 South and Central America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Application
11.5.6 South and Central America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Infection Type
11.5.7 South and Central America Hospital-Acquired Infection Diagnostics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Hospital-Acquired Infection Diagnostics Market
11.5.7.1.1 Brazil Hospital-Acquired Infection Diagnostics Market by Product
11.5.7.1.2 Brazil Hospital-Acquired Infection Diagnostics Market by Test Type
11.5.7.1.3 Brazil Hospital-Acquired Infection Diagnostics Market by Application
11.5.7.1.4 Brazil Hospital-Acquired Infection Diagnostics Market by Infection Type
11.5.7.2 Argentina Hospital-Acquired Infection Diagnostics Market
11.5.7.2.1 Argentina Hospital-Acquired Infection Diagnostics Market by Product
11.5.7.2.2 Argentina Hospital-Acquired Infection Diagnostics Market by Test Type
11.5.7.2.3 Argentina Hospital-Acquired Infection Diagnostics Market by Application
11.5.7.2.4 Argentina Hospital-Acquired Infection Diagnostics Market by Infection Type
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET, KEY COMPANY PROFILES
13.1. BIOMéRIEUX
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ABBOTT LABORATORIES
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ALERE, INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ROCHE AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SIEMENS HEALTHCARE
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BECTON DICKENSON
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CEPHEID INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. THERMO FISHER SCIENTIFIC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SEEGENE, INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. QIAGEN
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- BioMerieux
- Abbott Laboratories
- Alere, Inc.
- Roche AG
- Siemens Healthcare
- Becton Dickenson
- Cepheid Inc.
- Thermo Fisher Scientific
- Seegene, Inc.
- Qiagen